<DOC>
	<DOCNO>NCT00348231</DOCNO>
	<brief_summary>The purpose study compare whether difference effect insulin therapy number time insulin injection .</brief_summary>
	<brief_title>Jikei Optimal Insulin Therapy Type 2 Diabetes</brief_title>
	<detailed_description>The current insulin therapy divide conventional insulin therapy ( 1~2 injection per day ) intensive insulin therapy ( 3~4 injection per day ) . The kinetics exogenous insulin intensive insulin therapy imitate kinetics insulin secretion healthy person . A previous large clinical study ( e.g . DCCT , Kumamoto study , etc . ) suggest intensive insulin therapy prevent microangiopathy macroangiopathy , inhibited progression , however many patient chose conventional insulin therapy many hop injected insulin possible . The patient think life style disturb many time insulin injection . The current dual-acting insulin make insulin part modify protamine able suppress postprandial hyperglycemia . The new insulin may possibly kinetics insulin patient use insulin intensive insulin therapy . Moreover , patient receive insulin therapy easily time insulin injection few . It may lead perform effective insulin therapy search optimal insulin therapy induction type 2 diabetes . comparison : HbA1c , glycated albumin , IMT , lipid profile , body weight , daily profile blood glucose , conventional insulin therapy intensive insulin therapy .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Clinical diagnosis Type 2 diabetes secondary failure SU drug whose age 80 20 year old complication allergy insulin pregnant</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>diabetes mellitus , biphasic insulin analogue</keyword>
</DOC>